Home532989 • BOM
add
Bafna Pharmaceuticals Ltd
Previous close
₹101.05
Day range
₹102.50 - ₹111.15
Year range
₹67.80 - ₹111.15
Market cap
2.59B INR
Avg Volume
2.00K
P/E ratio
63.15
Dividend yield
-
Primary exchange
NSE
Market news
Investor's Business Daily
1 day ago
S&P 500 Titans Amazon And Netflix Lead Five Stocks Near Buy Points
0.68%
0.29%
Financials
Income Statement
Revenue
Net income
| (INR) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 346.24M | 4.02% |
Operating expense | 85.08M | 1.01% |
Net income | 33.89M | 568.34% |
Net profit margin | 9.79 | 551.15% |
Earnings per share | — | — |
EBITDA | 49.21M | 384.39% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 34.33M | 145.90% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 848.06M | — |
Shares outstanding | 23.70M | — |
Price to book | 2.84 | — |
Return on assets | — | — |
Return on capital | 8.18% | — |
Cash Flow
Net change in cash
| (INR) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 33.89M | 568.34% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1981
Website
Employees
363
